The European CAR-T map - Current status and future directions to improve access to CAR T-cell therapy for hematologic malignancies
Elise R. A. Pennings(Lymphoma Study Association), :unav, Jana Mihályová(University of Ostrava), Florence Broussais(Institut Calot), Samantha Nier(Advocates for Youth), Robin Doeswijk(European Hematology Association), Carmen Sanges(Augenklinik Universitätsklinikum Würzburg), Frederick W. Thielen(University Medical Center Freiburg), Lutgart Roux-Opstaele(Institut National du Cancer), Carin A. Uyl-de Groot, Ulrich Jaeger, Marie José Kersten, Barbara Huber, Catherine Thièblemont, Michaela Hornakova, Caroline Dreuillet, Natacha Bolaños, Julio Delgado, Roman Hájek, Michael Hudecek, Olga Millán, Yolanda Cabrerizo(European Hematology Association), Eglys B. González-Marcano, Solène Clavreul(European Federation of Allergy and Airways Diseases Patients Associations)
Cited by 0
Related Papers
Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation
|New England Journal of Medicine|2020|418
Anticoagulation with or without Clopidogrel after Transcatheter Aortic-Valve Implantation
|New England Journal of Medicine|2020|345
How to prepare a systematic review of economic evaluations for clinical practice guidelines: database selection and search strategy development (part 2/3)
|Expert Review of Pharmacoeconomics & Outcomes Research|2016|138
Health Economic Aspects of Chimeric Antigen Receptor T-cell Therapies for Hematological Cancers: Present and Future
|HemaSphere|2021|52
Long-term economic consequences of child maltreatment: a population-based study
|European Child & Adolescent Psychiatry|2016|44